Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 23/09/20241 min de leitura
Progynon Associates, et al.; Withdrawal of Approval of Four New Drug Applications
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is withdrawing approval of four new drug applications (NDAs) from multiple holders of those NDAs. The basis for the withdrawal is that these NDA holders have repeatedly failed to file required annual reports for the identified NDAs.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →